36C24E26Q0028_1.docx
DOCX document 27 KB Posted
- Attached to
- B529--Prostate Cancer-Specific Sequencing Services Federal contract opportunity
- Solicitation number
- 36C24E26Q0028
About this file
This is a Pre-Solicitation Notice for a sole source contract award. The Department of Veterans Affairs Regional Procurement Office East intends to negotiate a one-year base period contract with two option years with The Broad Institute, Inc. (located at 415 Main Street, Cambridge, Massachusetts) for prostate cancer-specific sequencing services to support the San Francisco VA Healthcare System. The contract is expected to be awarded under FAR 6.302.1-1 (Only One Responsible Source) with a response deadline of April 6, 2026 at 11:59 PM Eastern Time. The Contracting Officer is Ms. Millicent Covert (millicent.covert@va.gov). This notice applies NAICS code 541380 with a $19 million size standard and PSC code B529.
The scope of work includes prostate cancer-specific sequencing services over a three-year period to support Dr. Franklin W. Huang's VA Merit award study. The vendor shall perform PCR+ Human Whole Genome Sequencing at 30x coverage (150 samples) and 60x coverage (150 samples) using FFPE-compatible workflows with DRAGEN analysis. Deliverables include FASTQ, BAM, and VCF files with quality metrics (Q30 and coverage uniformity), tumor-normal matched sequencing, secure data transfer methods, and proper anonymization and handling of veteran samples. The work supports two research aims: Aim 1 utilizes 60 previously collected tissue samples and 40 prospectively collected samples from African American men undergoing radical prostatectomy, while Aim 3 requires prospective enrollment of 20 patients over four years for prostate epithelial organoid generation and single-cell RNA sequencing analysis. The sole source justification emphasizes the vendor's unique prostate cancer-specific sequencing protocol optimized for low tumor content and heterogeneous clinical specimens, which is critical to avoid data failure risk and delays to the veteran patient study timeline.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Special Notice Special Notice
| SUBJECT* |
| Prostate Cancer-Specific Sequencing Services |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 15215-1802 |
| SOLICITATION NUMBER* |
| 36C24E26Q0028 |
| RESPONSE DATE/TIME/ZONE |
| 04-06-2026 11:59 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 30 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
| PRODUCT SERVICE CODE* |
| B529 |
| NAICS CODE* |
| 541380 |
| CONTRACTING OFFICE ADDRESS |
| Veterans Health Administration |
Regional Procurement Office East Building 32 Suite 1A1111 1010 Delafield Road Pittsburgh PA 15215-1802
POINT OF CONTACT*
Contracting Officer Ms. Millicent Covert millicent.covert@va.gov (Calls shall not be accepted)
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
Pre-Solicitation Notice for the notice of intent to award a sole source contract. This is not a solicitation. Regional Procurement Office (RPO) - East intends to negotiate a sole source contract for a one (1) year base period to include two (2) option years with The Broad Institute, Inc., located at 415 Main Street, Cambridge, Massachusetts, for the San Francisco VA Healthcare System (SFVAHCS) for its prostate cancer-specific sequencing services. These services are essential to VA Merit award study under Dr. Franklin W. Huang, MD, Ph. D.
Background:
Franklin W. Huang, MD PhD VA Merit award has tumor sequencing requirements across Aim 1 and Aim 3. The vendor has a prostate cancer-specific sequencing protocol critical to the success of both aims.
· Aim 1: Utilizes previously collected tissue samples (N=60) from the SFVAHCS Department of Pathology and prospectively collected samples (n=40) from African American men undergoing radical prostatectomy. All samples are from Veterans and have already been collected at SFVAHCS.
· Aim 3: Requires prospective enrollment of 20 patients (of the 40 from Aim 2) over 4 years. This aim involves generating prostate epithelial organoid lines for genetic perturbations and single-cell RNA sequencing analysis.
Scope:
Vendor shall perform prostate cancer-specific sequencing for the SFVAHCS over a 3-year period. This includes:
· Minimum 30x and 60x coverage
· FFPE-compatible workflow
· Tumor-normal matched sequencing
· FASTQ, BAM, VCF file delivery
· Quality metrics (Q30, coverage uniformity, etc.)
· Secure data transfer method
· PCR+ Human WGS - 30x v3_FFPE_DRAGEN - 150 Samples
· PCR+ Human WGS - 60x v3_FFPE_DRAGEN – 150 Samples
Specific Tasks:
· Perform PCR+ Human WGS - 30x v3_FFPE_DRAGEN for 150 samples
· Perform PCR+ Human WGS - 60x v3_FFPE_DRAGEN for 150 samples
· Ensure anonymization and secure handling of all samples
· Provide tumor and normal genome sequencing specific to prostate cancer tissue
The requirement for a prostate cancer-specific sequencing protocol is a unique and corroborated capability that makes this vendor the only one capable of meeting the Government's needs. This protocol is important for the success of Aim 1 and Aim 3 of Dr. Huang’s VA Merit award because:
· Tissue Specificity: Prostate cancer tissue samples, particularly those from clinical biopsies, often have low tumor content and exhibit high degrees of heterogeneity. The requested vendor's established protocol is uniquely optimized to handle these challenging specimens, ensuring sufficient data yield and quality for both the Whole Genome Sequencing (WGS) runs (30x and 60x) and downstream analysis.
· Downstream Research Impact (Aim 3): The WGS data directly informs the generation of prostate epithelial organoid lines and subsequent single-cell RNA sequencing analysis in Aim 3. Using a non-specific or unvalidated protocol would introduce significant data failure risk, rendering the downstream genetic perturbations and analysis unreliable.
· Cost and Delay: Mandating the use of an unproven protocol would necessitate re-sequencing samples, leading to a substantial duplication of cost and a significant delay to the 4-year prospective enrollment schedule for the veteran patients in the study. This would jeopardize the success and integrity of the federally funded research.
Since the intent is to procure this on a sole source basis, no solicitation will be posted to SAM.gov Contract Opportunities. The applicable NAICS code is 541380, with a $19M size standard. The PSC is B529. The authority for this action is FAR 6.302.1-1 Only One Responsible source, and no other supplies or services will satisfy agency requirements.
Interested persons may contact the Contracting Officer via email at millicent.covert@va.gov regarding this procurement. The determination to conduct a competitive procurement based on responses to this notice is solely within the discretion of the Contracting Officer.
| *= Required Field |
| Special Notice |
Special Notice
File details come from the government source that posted it. Updated .